IMNN

NASDAQ · Biotechnology

Imunon Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$3.27

+0.20 (+6.51%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +656.6% upside

Low Target $16.96

Average Target $24.74

High Target $28.19

Current Price $3.27

Current
$3.27

Target
$24.74

$16.96 $24.74 avg $28.19

Scenario Analysis

Bear Case

$16.96

418.7%

Low target

Base Case

$24.74

+656.6%

Avg target

Bull Case

$28.19

+762.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$27.72

-88.2% from high

52-Week Low

$13.24

+-75.3% from low

Target vs 52W High

$24.74

-10.8% vs high

Next Earnings Report

Feb 25, 2026 · After Market Close

until earnings

EPS Est: $-1.19

Earnings in 9 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%